data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Jazz Pharmaceuticals
(NASDAQ:JAZZ)
$156.54
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$156.54
PreMarket: 4:32PM EDT
Day Range- - -52 Wk Range119.64 - 169.98Open / Close- / -Float / Outstanding55M / 63M
Vol / Avg.- / 536.8KMkt Cap9.9BP/E-50d Avg. Price140.7
Div / Yield-Payout Ratio-Total Float55MEPS-0.31

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range119.64 - 169.98Open / Close- / -Float / Outstanding55M / 63M
Vol / Avg.- / 536.8KMkt Cap9.9BP/E-50d Avg. Price140.7
Div / Yield-Payout Ratio-Total Float55MEPS-0.31
Johnny Rice -
Lisa Levin - 3 days ago
Vandana Singh - Nov 21, 2022, 2:32PM
Vandana Singh - Nov 21, 2022, 8:40AM
Nicolás Jose Rodriguez - Nov 10, 2022, 9:07AM
Vandana Singh - Oct 26, 2022, 12:52PM
Vandana Singh - Oct 21, 2022, 1:35PM
Vandana Singh - Oct 19, 2022, 7:29AM
Jelena Martinovic - Sep 29, 2022, 2:28PM
PRNewswire - 3 days ago
PRNewswire - Nov 18, 2022, 1:00PM
PRNewswire - Nov 14, 2022, 9:00AM
PRNewswire - Nov 9, 2022, 4:05PM
PRNewswire - Nov 3, 2022, 10:43AM
PRNewswire - Nov 1, 2022, 4:15PM
PRNewswire - Oct 26, 2022, 4:15PM
Business Wire - Oct 19, 2022, 6:07AM
PRNewswire - Oct 19, 2022, 6:00AM
PRNewswire - Sep 29, 2022, 12:59PM
PRNewswire - Sep 15, 2022, 4:30PM
PRNewswire - Aug 31, 2022, 4:15PM
PRNewswire - Aug 18, 2022, 7:30AM
PRNewswire - Aug 10, 2022, 8:30AM
PRNewswire - Aug 3, 2022, 4:05PM
PRNewswire - Jul 20, 2022, 4:15PM
PRNewswire - Jun 28, 2022, 7:30AM
PRNewswire - Jun 7, 2022, 7:30AM
PRNewswire - Jun 1, 2022, 4:15PM
PRNewswire - Jun 1, 2022, 7:45AM
PRNewswire - May 26, 2022, 8:50AM
PRNewswire - May 12, 2022, 11:57AM
Globe Newswire - May 9, 2022, 8:57AM
PRNewswire - May 9, 2022, 7:48AM
PRNewswire - May 9, 2022, 7:00AM
PRNewswire - May 9, 2022, 7:00AM
PRNewswire - May 4, 2022, 4:10PM
PRNewswire - May 4, 2022, 4:05PM
PRNewswire - May 3, 2022, 4:15PM
PRNewswire - May 2, 2022, 7:05AM
PRNewswire - Apr 20, 2022, 4:15PM
PRNewswire - Apr 8, 2022, 1:00PM
PRNewswire - Apr 7, 2022, 7:00AM
TalkMarkets - 1 day ago
InvestorsObserver - 1 day ago
Seeking Alpha - 1 day ago
TalkMarkets - 3 days ago
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 23, 2022, 10:32AM
TipRanks - Nov 18, 2022, 4:18PM
Seeking Alpha - Nov 18, 2022, 3:04PM
Seeking Alpha - Nov 18, 2022, 2:01PM
InvestorsObserver - Nov 17, 2022, 2:11PM
Seeking Alpha - Nov 15, 2022, 8:00AM
TipRanks - Nov 14, 2022, 6:56PM
TipRanks - Nov 14, 2022, 6:56PM
TipRanks - Nov 13, 2022, 11:01PM
Seeking Alpha - Nov 11, 2022, 2:02PM
TipRanks - Nov 10, 2022, 10:05AM
TipRanks - Nov 10, 2022, 8:40AM
TipRanks - Nov 10, 2022, 6:16AM
TipRanks - Nov 10, 2022, 5:15AM
Seeking Alpha - Nov 9, 2022, 11:30PM
Seeking Alpha - Nov 9, 2022, 5:11PM
InvestorsObserver - Nov 9, 2022, 2:09PM
Seeking Alpha - Nov 8, 2022, 5:35PM
InvestorsObserver - Nov 3, 2022, 3:13PM
InvestorsObserver - Nov 1, 2022, 3:52PM
InvestorPlace - Oct 31, 2022, 7:20PM
Seeking Alpha - Oct 31, 2022, 1:50AM
Seeking Alpha - Oct 30, 2022, 2:30AM
TipRanks - Oct 27, 2022, 9:51PM
Seeking Alpha - Oct 26, 2022, 9:02AM
TipRanks - Oct 25, 2022, 2:20PM
Seeking Alpha - Oct 23, 2022, 11:17PM
Seeking Alpha - Oct 21, 2022, 9:29AM
TipRanks - Oct 19, 2022, 2:05PM
InvestorPlace - Oct 19, 2022, 10:13AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS4.6605.170 0.5100
REV939.060M940.652M1.592M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 192.00 expecting JAZZ to rise to within 12 months (a possible 22.65% upside). 18 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $156.54 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.